These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30646091)

  • 1. Comparison of Clinical Outcomes Among Patients With Atrial Fibrillation or Atrial Flutter Stratified by CHA2DS2-VASc Score.
    Lin YS; Chen YL; Chen TH; Lin MS; Liu CH; Yang TY; Chung CM; Chen MC
    JAMA Netw Open; 2018 Aug; 1(4):e180941. PubMed ID: 30646091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of solitary atrial flutter patients using anticoagulation therapy: a national cohort study.
    Chen YL; Lin YS; Wang HT; Liu WH; Chen HC; Chen MC
    Europace; 2019 Feb; 21(2):313-321. PubMed ID: 30107472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposed A
    Chen YL; Wang HT; Chen HC; Liu WH; Chong SZ; Hsueh SK; Chung CM; Lin YS
    Open Heart; 2021 Jan; 8(1):. PubMed ID: 33514633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different Implications of Heart Failure, Ischemic Stroke, and Mortality Between Nonvalvular Atrial Fibrillation and Atrial Flutter-a View From a National Cohort Study.
    Lin YS; Chen TH; Chi CC; Lin MS; Tung TH; Liu CH; Chen YL; Chen MC
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28733435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation/atrial flutter patients.
    Naccarelli GV; Panaccio MP; Cummins G; Tu N
    Am J Cardiol; 2012 May; 109(10):1526-33. PubMed ID: 22360819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHA2DS2-VASC Score Predicts the Risk of Stroke in Patients Hospitalized to the Internal Medicine Department Without Known Atrial Fibrillation.
    Lahad K; Maor E; Klempfner R; Grossman C; Druyan A; Ben-Zvi I
    J Gen Intern Med; 2022 Oct; 37(13):3355-3360. PubMed ID: 35622270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation.
    Chao TF; Lip GYH; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Chen SA
    J Am Coll Cardiol; 2018 Jan; 71(2):122-132. PubMed ID: 29325634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke prediction with CHA
    Hu WS; Lin CL
    J Clin Neurosci; 2017 Nov; 45():193-198. PubMed ID: 28684149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
    J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of first-ever stroke in younger patients with atrial fibrillation not recommended for antithrombotic therapy by current guidelines: a population-based study in an East Asian cohort of 22 million people.
    Chang KC; Wang YC; Ko PY; Wu HP; Chen YW; Muo CH; Sung FC; Li TC; Hsu CY
    Mayo Clin Proc; 2014 Nov; 89(11):1487-97. PubMed ID: 25444485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.
    Lip GYH; Murphy RR; Sahiar F; Ingall TJ; Dhamane AD; Ferri M; Hlavacek P; Preib MT; Keshishian A; Russ C; Rosenblatt L; Yuce H; Deitelzweig S
    JAMA Netw Open; 2022 Aug; 5(8):e2229333. PubMed ID: 36044214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHA
    Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on secondary data from Germany.
    Wicke FS; Schaller MA; Karymova K; Beyer M; Müller BS
    BMC Cardiovasc Disord; 2019 Apr; 19(1):94. PubMed ID: 31014253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant).
    Gažová A; Leddy JJ; Rexová M; Hlivák P; Hatala R; Kyselovič J
    Medicine (Baltimore); 2019 Aug; 98(31):e16560. PubMed ID: 31374021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Lip GY; Chen SA
    Heart Rhythm; 2014 Oct; 11(10):1752-9. PubMed ID: 24952148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Chao TF; Lip GY; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
    Stroke; 2016 Oct; 47(10):2462-9. PubMed ID: 27625386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA
    Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Lip GYH; Marín F
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28729407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-World Comparison of Classes IC and III Antiarrhythmic Drugs as an Initial Rhythm Control Strategy in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
    Kipp R; Askari M; Fan J; Field ME; Turakhia MP
    JACC Clin Electrophysiol; 2019 Feb; 5(2):231-241. PubMed ID: 30784696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.